MUZZONIGRO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 6.998
EU - Europa 4.810
AS - Asia 1.431
AF - Africa 86
SA - Sud America 55
Continente sconosciuto - Info sul continente non disponibili 14
Totale 13.394
Nazione #
US - Stati Uniti d'America 6.976
IT - Italia 1.130
UA - Ucraina 1.073
DE - Germania 579
IE - Irlanda 536
SE - Svezia 518
SG - Singapore 446
DK - Danimarca 408
TR - Turchia 385
CN - Cina 297
FI - Finlandia 246
KR - Corea 233
FR - Francia 139
GB - Regno Unito 110
CI - Costa d'Avorio 63
BR - Brasile 48
IN - India 28
BE - Belgio 27
CA - Canada 16
MA - Marocco 16
NL - Olanda 13
EU - Europa 12
HK - Hong Kong 11
ID - Indonesia 9
RU - Federazione Russa 7
CH - Svizzera 5
MX - Messico 5
PL - Polonia 5
PE - Perù 4
VN - Vietnam 4
IR - Iran 3
LY - Libia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
HR - Croazia 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
PH - Filippine 2
VA - Santa Sede (Città del Vaticano) 2
AM - Armenia 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.394
Città #
Jacksonville 1.083
Chandler 771
Fairfield 603
Dublin 536
Boardman 512
Wilmington 457
Ashburn 383
Des Moines 289
Woodbridge 271
New York 261
Seattle 259
Lawrence 218
Princeton 218
San Mateo 217
Singapore 194
Ann Arbor 183
Houston 181
Cambridge 135
Centro 89
Milan 84
San Diego 73
Abidjan 63
Rome 51
Berlin 49
Beijing 39
Porto 31
Helsinki 28
Brussels 27
Norwalk 27
Frederico Westphalen 25
Turin 24
Guangzhou 23
London 22
Shanghai 21
Redmond 20
Pune 19
Florence 17
Izmir 17
Naples 17
Palermo 17
Caserta 15
Perugia 15
Seoul 15
Bari 14
Dallas 14
Los Angeles 14
Ancona 13
Marche 13
Wuhan 13
Hamburg 12
Washington 11
Petritoli 10
Bologna 9
Lamezia Terme 9
Auburn Hills 8
Brescia 8
Casavatore 8
Delhi 8
Falls Church 8
Pescara 8
Shenzhen 8
Jiaxing 7
Kilburn 7
Osio Sopra 7
Ottawa 7
Rapagnano 7
Rimini 7
Genoa 6
Hong Kong 6
Laives 6
Tappahannock 6
Vicenza 6
Wuxi 6
Yiwu 6
Beelitz 5
Fayetteville 5
Gorizia 5
Pesche 5
Simi Valley 5
Trento 5
Troia 5
Acton 4
Beauharnois 4
Bitonto 4
Borkum 4
Brasília 4
Cagliari 4
Campeche 4
Corridonia 4
Hangzhou 4
Hanoi 4
Jinan 4
Jinhua 4
Langwedel 4
Orta di Atella 4
Parma 4
Venice 4
Vibonati 4
West Jordan 4
Aparecida de Goiania 3
Totale 7.981
Nome #
Isosorbide dinitrato per la disfunzione erettile 652
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 186
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 128
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 113
Tolerability of prostate transrectal biopsies using gel and local anesthetics: Results of a randomized clinical trial 113
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 106
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 105
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 103
Primary B-cell lymphoblastic lymphoma of the testis 100
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 100
FUNCTIONAL OUTCOME EVALUATION AFTER REHABILITATION OF PELVIC FLOOR AFTER ROBOTIC RADICAL PROSTATECTOMY (RARP) VERSUS RETROPUBIC RADICAL PROSTATECTOMY (RRP) 96
Salvage cryosurgery for recurrent prostate carcinoma after radiotherapy 96
Effect of LHRH agonist and flutamide (combined endocrine therapy) ont he frequency and location of proliferating cell nuclear antigen and apoptotic bodies in prostatic hyperplasia. 93
Progress of molecular targeted therapies for advanced renal cell carcinoma. 92
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 88
Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience 88
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 87
Prognostic role of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1alfa (HIF-1alfa) in patients with conventional clear cell renal carcinoma after radical nephrectomy in a long term follow-up 86
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 86
Molecular pathology of non-invasive urothelial carcinoma (part I) - Review article 85
A conservative approach to perineal Fournier's Gangrene 85
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 84
Onabotulinum-Toxin-A in Urology: An Update. A Review of Recent Publications about Lower Urinary Tract Dysfunction Managed With Botulinum Toxin 84
Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients 83
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 83
Acupunctural reflexotherapy in the treatment of of sensory urgency that persists after transurethral resection of the prostate: a preliminary report 82
464 Cost comparison for different medical treatments in conservative — expulsive therapy of distal ureteral stones 82
Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections 82
Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy? 82
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 82
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 81
Transurethral resection versus minimally invasive trreatments of benign prostatic hyperplasia. Results of treatments. Our experience 80
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 80
INTRAPROSTATIC FIDUCIAL MARKERS' STABILITY DURING RADIATION TREATMENT 80
Nostra esperienza sulla caratterizzazione biologica "in vitro" degli adenocarcinomi renali stadio pT1 79
Urinary catheters and biofilm formation 79
Association between trauma and cancer of the testis: the importance of self-palpation of the testis for the early detection: two case reports. 78
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 78
Comparison between WHO (World Health Organization) 2010 and WHO 1999 parameters for semen analysis - interpretation of 529 consecutive samples. 78
Nodular hyperplasia of the prostate: quantitative evaluation of secretrory cell changes after treatment with finasteride. 77
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 76
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 76
Cystic lesions of the prostate gland: an ultrasound classification withpathological correlation 75
Cardiovascular effect of sildenafil in hypertensive men with erectile dysfunction and different alleles type 5-pmp-specific phosphodiesterase (PDE5) 75
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 75
Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy 75
Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates. 75
The production of serum free and total prostate specific antigen by prostatic intraepithelial neoplasia (PIN) 73
370Ultrasound evaluation of bladder neck complex alterations in chronic prostatitis/chronic pelvic pain syndrome 73
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 73
Randomized trial on the efficacy of tamsulosin, nifedipine and phloroglucinol in medical-expulsive therapy of distal ureteral calculi. 72
Conservative management of juxtavesical calculi with tamsulosin 72
Nebivolol induces, via β3 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes. 72
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 71
602 SIMULTANEOUS TURB-TURP IN PATIENTS WITH BLADDER CANCER AND BPH: A PROSPECTIVE RANDOMIZED TRIAL ON RELAPSES OCCURRENCE AND TREATMENT-RELATED QUALITY OF LIFE 71
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 71
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 71
Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy. 71
The effect of the enkephalin DADLE on trascription does not depend on opioid receptors 70
Effect of combination endocrine therapy (LHRH Agonist and Flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA) 70
Premature ejaculation: results from a five-country European observational study. 70
Identificazione dell’enzima nicotinamide n-metiltransferasi quale marker molecolare del carcinoma renale a cellule chiare. 70
Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis. 70
MVCT AND INTRAPROSTATIC MARKERS MAKE FEASIBLE THE TREATMENT OF PATIENTS WITH BILATERAL HIP PROSTHESIS 70
Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis-chronic pelvic pain syndrome 69
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 69
Biomarkers for VEGF-targeted therapy in renal cell carcinoma: an UpTo Date 69
Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth 69
Clinical pathology of prostate cancer: focus on diagnosis, predicitive and prognostic factors and quality indicators. 68
465 Alpha1 adrenoceptor subtypes in men juxtavesical ureters: Molecular and pharmacological characterization 68
Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma 68
Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents. 67
Safety and efficacy of transurethral resection of prostate gland up to 150 mls: a prospective comparative study with 1 year follow-up 67
Correlation between urodyanamics and perineal ultrasound in female patients with urinary incontinence. 67
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 67
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 67
Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life 66
Prognostic role of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1alfa (HIF-1alfa) in patients with conventional clear cell renal carcinoma after radical nephrectomy in a long term follow-up 66
Nodular hyperplasia of the prostate - Quantitative evaluation of secretory cell changes after treatment with finasteride. 65
[Isolated hydatid cyst of the kidney]. 64
Analisi del DNA e mutazione precoce del gene p53 nei carcinomi renali di piccole dimensioni 64
Fragments of prostatic biopsy: characteristics, dimensions, and number. 64
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 63
Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy 63
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 62
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 62
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 61
Cryptorchidism and infertility: retrospective study of 18 post puberal patients affected with monolateral cryptorchidism. 61
Intraprostatic spread of prostatic carcinoma: stereographic representation based on ultrasonography and biopsy findings. 61
Evidence for the presence of a1 adrenoreceptor subtypes in the human ureter 60
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 60
Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience. 60
Solitary fibrous tumour of the prostate identified on needle biopsy 60
Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice 59
Biology and natural history of prostatic cancer: necessity of early diagnostic screening. 59
Sacral neuromodulation in patients with multiple sclerosis. 59
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 59
Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. 58
RNA-III inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection 58
Skin metastasis from prostate cancer associated with malignant melanoma 58
Totale 8.246
Categoria #
all - tutte 70.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020810 0 0 0 0 0 14 225 14 228 27 25 277
2020/20212.447 108 301 357 38 309 108 277 140 277 151 286 95
2021/20221.517 56 414 11 131 19 76 43 119 109 123 91 325
2022/20232.641 262 265 220 199 193 487 4 123 659 21 137 71
2023/20241.971 290 55 93 305 288 364 59 77 16 80 95 249
2024/20251.226 318 334 188 84 198 104 0 0 0 0 0 0
Totale 13.625